Seattle, WA, United States of America

Do Yeon Kwon

This inventor holds 9 USPTO granted patents and 8 published patent applications. Top assignees: Omeros Corporation, Wilmington Savings Fund Society, Fsb, as Collateral Agent. Active years: 2023-2026.

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Work of Inventor Do Yeon Kwon

Introduction:

Do Yeon Kwon, a talented innovator based in Seattle, WA (US), has made significant contributions to the field of biotechnology. With three patents to his name, Kwon's expertise lies in developing cutting-edge solutions for complex medical challenges.

Latest Patents:

Kwon's latest patents focus on MASP-2 inhibitors and methods of use. These groundbreaking inventions showcase his ability to create compounds with MASP-2 inhibitory activity, along with compositions and methods for their production and application.

Career Highlights:

Currently employed at Omeros Corporation, a renowned biopharmaceutical company, Kwon plays a pivotal role in driving innovation and research in the industry. His dedication to advancing medical technology has earned him recognition among his peers.

Collaborations:

Kwon collaborates closely with accomplished individuals in the field, including notable coworkers such as Neil S Cutshall and Jennifer Lynn Gage. Together, they form a dynamic team that thrives on creativity and problem-solving.

Conclusion:

Inventor Do Yeon Kwon's journey is a testament to his unwavering commitment to pushing the boundaries of science and technology. His passion for creating impactful solutions underscores his status as a visionary in the world of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…